Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies

PURPOSE: Complete metastasectomy of renal cell carcinoma (RCC) is receding into the past due to the progress of immuno-oncology-based combinations (IO) in systemic therapy. The prognostic impact of curative intended complete metastasectomy vs. immediate IO-based therapy or tyrosine kinase inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Stühler, Viktoria, Herrmann, Lisa, Maas, Moritz, Walz, Simon, Rausch, Steffen, Stenzl, Arnulf, Bedke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085676/
https://www.ncbi.nlm.nih.gov/pubmed/35217885
http://dx.doi.org/10.1007/s00345-022-03960-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085676/
https://www.ncbi.nlm.nih.gov/pubmed/35217885
http://dx.doi.org/10.1007/s00345-022-03960-1

Ejemplares similares